% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • rothingham rothingham Jul 12, 2012 7:32 AM Flag

    GHDX profits vs competition

    New to ghdx, still doing my early due diligence on both the stock and the market. Am I correct that MYGN is a competitor, and if so, why is MYGN's profits (cash flow, operating cash flow, EBITDA) so much higher than GHDX? CPHD, which I also believe is a competitor, is right in line with GHDX. Comments and assistance from those much more knowledgeable than me greatly appreciated.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • With $1b of revenue, ghdx has $15m ebitda, $23m operating cash flow and $14m free cash flow. With twice the revenue ($2b), mygn has $184m ebitda, $136m operating cash flow, and $122m free cash flow. All figures via Yahoo. mygn is obviously an extremely profitable company, but I dont know if it is a true apples to apples comparison with ghdx and cphd. Any help appreciates.

29.91-0.04(-0.13%)4:00 PMEDT